Shareholding disclosure

Kuros Biosciences AG

Declared position

14.79%

Threshold

Crossed downwards

Timeline

Published

15.12.2016

Transaction

21.06.2016

Voting rights breakdown

Voting rights acquired0.4%

Voting rights sold14.79%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAGCD00077

Beneficial owner

Kuros Biosciences AG

Declared address

Kuros Biosciences AG, 8952 Schlieren

All information provided as at the date of 13 December 2016

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Kuros Biosciences AG

Kuros Biosciences AG15.12.2016TAGCD00077

Disclosure summary

Kuros Biosciences AG disclosed a holding in Kuros Biosciences AG on the disposal side, published by SIX Exchange Regulation on 15.12.2016, at 14.79% of voting rights. Notice category: Single shareholder.

Disclosed position

14.79%

Voting rights sold

Voting rights acquired0.4%

Voting rights sold14.79%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Kuros Biosciences AG disclosed a holding in Kuros Biosciences AG, published on 15.12.2016.

Publication date15.12.2016

Transaction date21.06.2016

Issuing companyKuros Biosciences AG

Beneficial ownerKuros Biosciences AG

Declared addressKuros Biosciences AG, 8952 Schlieren

CategorySingle shareholder

Voting rights acquired0.4%

Voting rights sold14.79%

Below threshold0%

ExchangeXSWX

Notification IDTAGCD00077

Commercial register

CHE-104.785.642

Registered

Zefix record

Conditions

All information provided as at the date of 13 December 2016

Source: SIX Exchange Regulation · Publication date: 15.12.2016

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open